Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and services company with a unique combina
Location: United Kingdom, England, Burton-on-Trent
Employees: 201-500
Phone: +44 1283 494340
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Triton | triton-par... |
Mentions in press and media 20
| Date | Title | Description |
| 12.02.2026 | Clinigen Announces World-First Pharmaceutical Approval for Prolacta Bioscience's PreemieFort® Enteral Solution, Human Milk-Based Product in Japan | Clinigen obtained approval for Prolacta's "PreemieFort® Enteral Solution", a human milk-based fortifier, as an approved pharmaceutical product in Japan indicated for the "Nutritional management of neonates and infants present... |
| 30.07.2025 | MaaT Pharma: €37.5 Million EIB Loan Secured To Advance Cancer Therapies | MaaT Pharma, a clinical-stage biotechnology company focused on Microbiome Ecosystem Therapies (MET) for cancer patients, has secured a €37.5 million loan from the European Investment Bank (EIB) to advance its late-stage hemato-oncology prog... |
| 27.09.2024 | Photocure establishes Named Patient Program to provide access to Hexvix in South Africa | Photocure establishes Named Patient Program to provide access to Hexvix in South Africa Fri, Sep 27, 2024 08:00 CET Report this content Press Release – Oslo, Norway, September 27, 2024: Photocure ASA (OSE: PHO), the Bladder Cancer Company, ... |
| 12.03.2024 | Real World Evidence/RWE Solutions Market is growing at a CAGR of 13.8% from 2024 to 2030 by Exactitude Consultancy | Real World Evidence (RWE) Solutions market The Exactitude Consultancy Real World Evidence/RWE Solutions Market Report – Size, Trends, and Forecast 2024-2030 The Real World Evidence (RWE) Solutions market is experiencing high demand due to i... |
| 20.03.2023 | Adragos Pharma acquires Clinigen's development unit, Lamda Laboratories | Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment Agreement includes further product development activities for Clinigen Limited Lamda spurs further growth for Adrag... |
| 24.05.2022 | Clinigen expands US site capacity in response to growing demand for Clinical Supplies Management services | 24 May 2022 Clinigen expands US site capacity in response to growing demand for Clinical Supplies Management services Clinigen Limited (‘Clinigen’ or the ‘Company’), the global pharmaceutical services company, announces it has nearly double... |
| 10.02.2022 | Humanigen Launches Managed Access Program for Lenzilumab | Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced today that lenzilumab is now available for certain hospitalized COVID-... |
| 02.09.2021 | PAION : SIGNS EXCLUSIVE UK SUPPLY AND DISTRIBUTION AGREEMENT WITH CLINIGEN | DGAP-News: PAION AG / Key word(s): Miscellaneous PAION SIGNS EXCLUSIVE UK SUPPLY AND DISTRIBUTION AGREEMENT WITH CLINIGEN 02.09.2021 / 14:00 The issuer is solely responsible for the content of this announcement. PAION SIGNS EXCLUSIVE UK SUP... |
| 08.04.2021 | CLINIGEN GROUP PLC Clinigen : launches Managed Access Program with BeiGene for zanubrutinib | medicineaccess@clinigengroup.com. 8 April 2021 Clinigen launches Managed Access Program with BeiGene for zanubrutinib Clinigen Group plc (AIM: CLIN, 'Clinigen'), the global pharmaceutical Products and Services company, has launched a Manage... |
| 06.04.2021 | CLINIGEN GROUP PLC Clinigen : to begin supplying Erwinase® in the UK | 6 April 2021 Clinigen to begin supplying Erwinase® in the UK Clinigen Group plc (AIM: CLIN, 'Clinigen'), the global pharmaceutical Products and Services company, today announces that it will be providing access to Erwinase® (L-asparaginaseE... |
Show more